135 related articles for article (PubMed ID: 12941370)
1. Group II metabotropic glutamate receptor antagonists LY341495 and LY366457 increase locomotor activity in mice.
O'Neill MF; Heron-Maxwell C; Conway MW; Monn JA; Ornstein P
Neuropharmacology; 2003 Oct; 45(5):565-74. PubMed ID: 12941370
[TBL] [Abstract][Full Text] [Related]
2. Blockade of group II metabotropic glutamate receptors produces hyper-locomotion in cocaine pre-exposed rats by interactions with dopamine receptors.
Yoon HS; Jang JK; Kim JH
Neuropharmacology; 2008 Sep; 55(4):555-9. PubMed ID: 18675831
[TBL] [Abstract][Full Text] [Related]
3. Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice.
O'Neill MF; Shaw G
Psychopharmacology (Berl); 1999 Aug; 145(3):237-50. PubMed ID: 10494572
[TBL] [Abstract][Full Text] [Related]
4. MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride.
Martin P; Waters N; Waters S; Carlsson A; Carlsson ML
Eur J Pharmacol; 1997 Sep; 335(2-3):107-16. PubMed ID: 9369362
[TBL] [Abstract][Full Text] [Related]
5. 5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB.
O'Neill MF; Heron-Maxwell CL; Shaw G
Pharmacol Biochem Behav; 1999 Jun; 63(2):237-43. PubMed ID: 10371652
[TBL] [Abstract][Full Text] [Related]
6. The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice.
Carlsson ML; Martin P; Nilsson M; Sorensen SM; Carlsson A; Waters S; Waters N
J Neural Transm (Vienna); 1999; 106(2):123-9. PubMed ID: 10226932
[TBL] [Abstract][Full Text] [Related]
7. Effects of D1 and D2 dopamine receptor antagonists and catecholamine depleting agents on the locomotor stimulation induced by dizocilpine in mice.
Lapin IP; Rogawski MA
Behav Brain Res; 1995 Oct; 70(2):145-51. PubMed ID: 8561905
[TBL] [Abstract][Full Text] [Related]
8. Combined administration of an mGlu2/3 receptor agonist and a 5-HT 2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants.
Uslaner JM; Smith SM; Huszar SL; Pachmerhiwala R; Hinchliffe RM; Vardigan JD; Hutson PH
Psychopharmacology (Berl); 2009 Nov; 206(4):641-51. PubMed ID: 19707745
[TBL] [Abstract][Full Text] [Related]
9. D1 and D2 dopamine receptors contribute to the locomotor response induced by Group II mGluRs activation in the rat nucleus accumbens.
Breysse N; Risterucci C; Amalric M
Pharmacol Biochem Behav; 2002 Sep; 73(2):347-57. PubMed ID: 12117589
[TBL] [Abstract][Full Text] [Related]
10. Activation of striatal group II metabotropic glutamate receptors has a differential effect on dopamine-D1 and -D2 receptor antagonist-induced hypokinesia in the rat.
Kronthaler UO; Schmidt WJ
Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):289-97. PubMed ID: 10731042
[TBL] [Abstract][Full Text] [Related]
11. Habituation deficits induced by metabotropic glutamate receptors 2/3 receptor blockade in mice: reversal by antipsychotic drugs.
Bespalov A; Jongen-Rêlo AL; van Gaalen M; Harich S; Schoemaker H; Gross G
J Pharmacol Exp Ther; 2007 Feb; 320(2):944-50. PubMed ID: 17135347
[TBL] [Abstract][Full Text] [Related]
12. Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists.
Chartoff EH; Heusner CL; Palmiter RD
Neuropsychopharmacology; 2005 Jul; 30(7):1324-33. PubMed ID: 15688082
[TBL] [Abstract][Full Text] [Related]
13. Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychotics.
Bradford AM; Savage KM; Jones DN; Kalinichev M
Psychopharmacology (Berl); 2010 Oct; 212(2):155-70. PubMed ID: 20676613
[TBL] [Abstract][Full Text] [Related]
14. Blockade of group II metabotropic glutamate receptors in the nucleus accumbens produces hyperlocomotion in rats previously exposed to amphetamine.
Chi H; Jang JK; Kim JH; Vezina P
Neuropharmacology; 2006 Oct; 51(5):986-92. PubMed ID: 16901517
[TBL] [Abstract][Full Text] [Related]
15. Differential modulation of the D1-like- and D2-like dopamine receptor-induced locomotor responses by group II metabotropic glutamate receptors in the rat nucleus accumbens.
David HN; Abraini JH
Neuropharmacology; 2001 Sep; 41(4):454-63. PubMed ID: 11543765
[TBL] [Abstract][Full Text] [Related]
16. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic basis for the facilitation of brain stimulation reward by the NMDA receptor antagonist, MK-801.
Olds ME
Eur J Pharmacol; 1996 Jun; 306(1-3):23-32. PubMed ID: 8813611
[TBL] [Abstract][Full Text] [Related]
18. Use of MGLUR2 and MGLUR3 knockout mice to explore in vivo receptor specificity of the MGLUR2/3 selective antagonist LY341495.
Linden AM; Johnson BG; Trokovic N; Korpi ER; Schoepp DD
Neuropharmacology; 2009 Aug; 57(2):172-82. PubMed ID: 19477188
[TBL] [Abstract][Full Text] [Related]
19. Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice.
Mele A; Castellano C; Felici A; Cabib S; Caccia S; Oliverio A
Eur J Pharmacol; 1996 Jul; 308(1):1-12. PubMed ID: 8836626
[TBL] [Abstract][Full Text] [Related]
20. Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test.
Fukumoto K; Iijima M; Chaki S
Psychopharmacology (Berl); 2014 Jun; 231(11):2291-8. PubMed ID: 24402133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
